Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions
Completed · Phase 3
Conditions studied: Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
In brief
RATIONALE: Genetics education and counseling may help patients make treatment decisions. It is not yet known how genetic counseling or usual care influence patient treatment decisions for breast cancer. PURPOSE: This randomized clinical trial is studying how well genetic counseling works compared to usual care in helping patients with newly diagnosed ductal carcinoma in situ, stage I, stage II, or stage IIIA breast cancer make treatment decisions.
Key facts
- Study ID
- NCT00262899
- Run by
- Georgetown University
- People needed
- 331
- Starts
- 2005-08-01
- Expected to finish
- 2011-07-01
- Last updated by the study team
- 2013-01-07
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center — Washington D.C., District of Columbia, United States
- Study site — Chevy Chase, Maryland, United States
- Hackensack University Medical Center Cancer Center — Hackensack, New Jersey, United States
- Mount Sinai School of Medicine — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.